Stockscreener 앱 받기
0.7821
4.62%
-0.0379
시간 외 거래:
.77
-0.0121
-1.55%
전일 마감가:
$0.82
열려 있는:
$0.8102
하루 거래량:
114.53K
Relative Volume:
0.51
시가총액:
$18.06M
수익:
-
순이익/손실:
$-13.49M
주가수익비율:
-0.1539
EPS:
-5.0823
순현금흐름:
$-12.26M
1주 성능:
-5.46%
1개월 성능:
-2.08%
6개월 성능:
+6.68%
1년 성능:
-31.99%
1일 변동 폭
$0.7602
$0.8698
1주일 범위
$0.7602
$0.8798
52주 변동 폭
$0.281
$3.79
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
명칭
Pasithea Therapeutics Corp
전화
(702) 514-4174
주소
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7821 | 18.93M | 0 | -13.49M | -12.26M | -5.0823 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pasithea Therapeutics Corp 주식(KTTA)의 최신 뉴스
Layoff Watch: What is the next catalyst for Pasithea Therapeutics Corp Equity WarrantQuarterly Market Review & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Gains Report: Is Pasithea Therapeutics Corp Equity Warrant attractive for institutional investors2026 Earnings Surprises & Consistent Return Investment Signals - baoquankhu1.vn
Analyst Calls: How does Pasithea Therapeutics Corp correlate with Nasdaq2026 Momentum & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Aug EndMonth: What is Pasithea Therapeutics Corp Equity Warrants revenue forecast2026 Institutional & Reliable Price Breakout Alerts - baoquankhu1.vn
Smart Money: Whats the beta of Pasithea Therapeutics Corp stock2026 Historical Comparison & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
KTTA Stock Price, Quote & Chart | PASITHEA THERAPEUTICS CORP (NASDAQ:KTTA) - ChartMill
Pullback Watch: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly priced2026 Price Action Summary & Stepwise Trade Signal Guides - baoquankhu1.vn
Fund Flows: Is Pasithea Therapeutics Corp Equity Warrant impacted by rising rates2026 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
Will Pasithea Therapeutics Corp. Equity Warrant stock recover faster than market2026 Patterns & Entry Point Strategy Guides - Naître et grandir
RSI Check: What is Pasithea Therapeutics Corp Equity Warrants revenue forecastJuly 2025 Rallies & Expert Approved Momentum Ideas - baoquankhu1.vn
Earnings Recap: Whats the beta of Pasithea Therapeutics Corp stockMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Fed Watch: Whats the beta of Pasithea Therapeutics Corp Equity Warrant stockIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn
Certain Options of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com
Certain Common Stock of Pasithea Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 3-MAR-2026. - marketscreener.com
KTTA PE Ratio & Valuation, Is KTTA Overvalued - Intellectia AI
KTTA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Coastlands entities hold 2.39M shares in Pasithea Therapeutics (NASDAQ: KTTA) - Stock Titan
KTTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
What’s next for Pasithea Therapeutics Corp. stockTrade Entry Report & AI Enhanced Execution Alerts - mfd.ru
Pasithea Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Pasithea Therapeutics (KTTA) faces Nasdaq $1 bid price deficiency and cure deadline - Stock Titan
CVI and Heights disclose 3.8% Pasithea (KTTA) stake via warrant holdings - Stock Titan
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Investing News Network
Pasithea Therapeutics Corp. to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026 - Quiver Quantitative
NF1-PN drug developer Pasithea to present at Oppenheimer event - Stock Titan
Can Pasithea Therapeutics Corp. disrupt its industryQuarterly Market Summary & Daily Stock Trend Reports - mfd.ru
KTTA Should I Buy - Intellectia AI
Published on: 2026-02-12 18:27:19 - mfd.ru
Aug Mood: How does Pasithea Therapeutics Corp. correlate with NasdaqJuly 2025 Setups & Smart Investment Allocation Tips - mfd.ru
Published on: 2026-02-12 00:18:47 - mfd.ru
Why Pasithea Therapeutics Corp. stock is seen as undervaluedTrade Analysis Summary & AI Forecast for Swing Trade Picks - mfd.ru
What’s the beta of Pasithea Therapeutics Corp. stockWeekly Trading Summary & Precise Buy Zone Identification - mfd.ru
Why Pasithea Therapeutics Corp. Equity Warrant stock could be next big winnerJuly 2025 Price Swings & Daily Market Momentum Tracking - mfd.ru
Earnings Miss: Is Pasithea Therapeutics Corp Equity Warrant stock overvalued or fairly pricedJuly 2025 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Dividend Watch: What is the Moat Score of Pasithea Therapeutics Corp Equity WarrantGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn
Aug Levels: Can Pasithea Therapeutics Corp disrupt its industryWeekly Loss Report & Weekly High Momentum Picks - baoquankhu1.vn
Meme Stocks: Can Beyond Meat Inc. navigate macro headwindsRate Cut & Weekly Sector Rotation Insights - baoquankhu1.vn
Jobs Data: What is the long term forecast for Pasithea Therapeutics Corp stockJuly 2025 Fed Impact & Long-Term Safe Investment Plans - baoquankhu1.vn
Weekly Earnings: Can Pasithea Therapeutics Corp disrupt its industryQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Institution Moves: Can Alerus Financial Corporation withstand a market correctionBond Market & Daily Entry Point Trade Alerts - baoquankhu1.vn
Is Pasithea Therapeutics Corp. stock influenced by commodity prices2025 Historical Comparison & Consistent Profit Trading Strategies - Mfd.ru
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization - TipRanks
Fundamentals Check: Is POET benefiting from innovation trends2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Performance Recap: Should I average down on WRAP stockMarket Movers & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Aug Shorts: Can Pasithea Therapeutics Corp sustain earnings growth2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
How does SWVL compare to its peersEarnings Recap Summary & High Yield Stock Recommendations - baoquankhu1.vn
Published on: 2026-01-22 13:20:30 - baoquankhu1.vn
Aug Big Picture: Is Finward Bancorp benefiting from interest rate changes2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Pasithea Therapeutics regains Nasdaq compliance - MSN
Pasithea Therapeutics Corp (KTTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pasithea Therapeutics Corp 주식 (KTTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
73,334 |
| Dumesnil Simon | Director |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
35,833 |
1.20%
0.06%
자본화:
|
볼륨(24시간):